Early research (Phase 1)Ended earlyNCT01948271What this trial is testingEfficacy Study of Trichuris Suis Ova to Treat Chronic Plaque PsoriasisWho this might be right forPsoriasis Tufts Medical Center 3
Large-scale testing (Phase 3)Study completedNCT01412944What this trial is testingEfficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forPlaque-type Psoriasis Novartis Pharmaceuticals 43
Not applicableLooking for participantsNCT07039110What this trial is testingStudy to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis AbbVie 700
Large-scale testing (Phase 3)Study completedNCT06011733What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis UCB Biopharma SRL 133
Testing effectiveness (Phase 2)Study completedNCT01230138What this trial is testingPivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Forward-Pharma GmbH 252
Large-scale testing (Phase 3)Study completedNCT03255382What this trial is testingAssess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic TherapyWho this might be right forPsoriasis AbbVie 120
Testing effectiveness (Phase 2)Study completedNCT00852670What this trial is testingACT-128800 in PsoriasisWho this might be right forPlaque Psoriasis Actelion 66
Testing effectiveness (Phase 2)Study completedNCT02899988What this trial is testingMirikizumab (LY3074828) in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Eli Lilly and Company 205
Large-scale testing (Phase 3)Active Not RecruitingNCT06630559What this trial is testingCompare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe PsoriasisWho this might be right forPlaque Psoriasis Celltrion 153
Large-scale testing (Phase 3)WithdrawnNCT01900782What this trial is testingEfficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.Who this might be right forPsoriasis Novartis Pharmaceuticals
Very early researchStudy completedNCT06555497What this trial is testingTopical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With PsoriasisWho this might be right forPilot StudyPsoriasis Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium 2
Large-scale testing (Phase 3)Study completedNCT02618759What this trial is testingClinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque PsoriasisWho this might be right forPlaque Psoriasis Sun Pharmaceutical Industries, Inc. 119
Testing effectiveness (Phase 2)Study completedNCT00646191What this trial is testingStudy of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Abbott 137
Large-scale testing (Phase 3)Study completedNCT01815424What this trial is testingA Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque PsoriasisWho this might be right forPsoriasis Pfizer 266
Testing effectiveness (Phase 2)Study completedNCT03000608What this trial is testingA Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque PsoriasisWho this might be right forPlaque Psoriasis Santalis Pharmaceuticals, Inc. 69
Large-scale testing (Phase 3)Study completedNCT03701763What this trial is testingEfficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Amgen 245
Testing effectiveness (Phase 2)WithdrawnNCT02993328What this trial is testingA Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in AdultsWho this might be right forPlaque Psoriasis Santalis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT05600036What this trial is testingEvaluate the Efficacy and Safety of ESK-001 in Patients With Plaque PsoriasisWho this might be right forPlaque Psoriasis Alumis Inc 228
Large-scale testing (Phase 3)Study completedNCT00237887What this trial is testingEfficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Abbott 1,212
Testing effectiveness (Phase 2)Study completedNCT02969018What this trial is testingStudy To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Pfizer 212